BACKGROUND:Decisional conflict is a source of anxiety and stress for men diagnosed with prostate cancer given uncertainty surrounding myriad treatment options. Few data exist to help clinicians identify which patients are at risk for decisional conflict. The purpose of this study was to examine factors associated with decisional conflict in economically disadvantaged men diagnosed with prostate cancer before any treatment choices were made. METHODS: A total of 70 men were surveyed at a Veterans Administration clinic with newly diagnosed localized prostate cancer enrolled in a randomized trial testing a novel shared decision-making tool. Baseline demographic, clinical, and functional data were collected. Independent variables included age, race, education, comorbidity, relationship status, urinary/sexual dysfunction, and prostate cancer knowledge. Tested outcomes were Decisional Conflict Scale, Uncertainty Subscale, and Perceived Effectiveness Subscale. Multiple linear regression modeling was used to identify factors associated with decisional conflict. RESULTS:Mean age was 63 years, 49% were African American, and 70% reported an income less than $30,000. Poor prostate cancer knowledge was associated with increased decisional conflict and higher uncertainty (P < .001 and P = 0.001, respectively). Poor knowledge was also associated with lower perceived effectiveness (P = 0.003) whereas being in a relationship was associated with higher decisional conflict (P = 0.03). CONCLUSIONS: Decreased patient knowledge about prostate cancer is associated with increased decisional conflict and lower perceived effective decision-making. Interventions to increase comprehension of prostate cancer and its treatments may reduce decisional conflict. Further work is needed to better characterize this relationship and identify effective targeted interventions.
RCT Entities:
BACKGROUND: Decisional conflict is a source of anxiety and stress for men diagnosed with prostate cancer given uncertainty surrounding myriad treatment options. Few data exist to help clinicians identify which patients are at risk for decisional conflict. The purpose of this study was to examine factors associated with decisional conflict in economically disadvantaged men diagnosed with prostate cancer before any treatment choices were made. METHODS: A total of 70 men were surveyed at a Veterans Administration clinic with newly diagnosed localized prostate cancer enrolled in a randomized trial testing a novel shared decision-making tool. Baseline demographic, clinical, and functional data were collected. Independent variables included age, race, education, comorbidity, relationship status, urinary/sexual dysfunction, and prostate cancer knowledge. Tested outcomes were Decisional Conflict Scale, Uncertainty Subscale, and Perceived Effectiveness Subscale. Multiple linear regression modeling was used to identify factors associated with decisional conflict. RESULTS: Mean age was 63 years, 49% were African American, and 70% reported an income less than $30,000. Poor prostate cancer knowledge was associated with increased decisional conflict and higher uncertainty (P < .001 and P = 0.001, respectively). Poor knowledge was also associated with lower perceived effectiveness (P = 0.003) whereas being in a relationship was associated with higher decisional conflict (P = 0.03). CONCLUSIONS: Decreased patient knowledge about prostate cancer is associated with increased decisional conflict and lower perceived effective decision-making. Interventions to increase comprehension of prostate cancer and its treatments may reduce decisional conflict. Further work is needed to better characterize this relationship and identify effective targeted interventions.
Authors: Steven B Zeliadt; Scott D Ramsey; David F Penson; Ingrid J Hall; Donatus U Ekwueme; Leonard Stroud; Judith W Lee Journal: Cancer Date: 2006-05-01 Impact factor: 6.860
Authors: Gunnar Steineck; Fred Helgesen; Jan Adolfsson; Paul W Dickman; Jan-Erik Johansson; Bo Johan Norlén; Lars Holmberg Journal: N Engl J Med Date: 2002-09-12 Impact factor: 91.245
Authors: Kathryn L Taylor; Randi M Williams; Kimberly Davis; George Luta; Sofiya Penek; Samantha Barry; Scott Kelly; Catherine Tomko; Marc Schwartz; Alexander H Krist; Steven H Woolf; Mary B Fishman; Carmella Cole; Edward Miller Journal: JAMA Intern Med Date: 2013-10-14 Impact factor: 21.873
Authors: Daniel S Wang; Ashesh B Jani; Caroline G Tai; Musu Sesay; Daniel K Lee; Michael Goodman; Katharina V Echt; Kerry E Kilbridge; Viraj A Master Journal: Cancer Date: 2013-06-03 Impact factor: 6.860
Authors: Jamie C Brehaut; Annette M O'Connor; Timothy J Wood; Thomas F Hack; Laura Siminoff; Elisa Gordon; Deb Feldman-Stewart Journal: Med Decis Making Date: 2003 Jul-Aug Impact factor: 2.583
Authors: Esther R Smith-Howell; Susan E Hickman; Salimah H Meghani; Susan M Perkins; Susan M Rawl Journal: J Palliat Med Date: 2016-02 Impact factor: 2.947
Authors: Michael J Nabozny; Jacqueline M Kruser; Nicole M Steffens; Karen J Brasel; Toby C Campbell; Martha E Gaines; Margaret L Schwarze Journal: Ann Surg Date: 2016-01 Impact factor: 12.969
Authors: Shannon M Nugent; Sara E Golden; Charles R Thomas; Mark E Deffebach; Mithran S Sukumar; Paul H Schipper; Brandon H Tieu; Drew Moghanaki; Juan Wisnivesky; Christopher Slatore Journal: Support Care Cancer Date: 2017-12-05 Impact factor: 3.603
Authors: R Schaffert; U Dahinden; T Hess; A Bänziger; P Kuntschik; F Odoni; P Spörri; R T Strebel; J Kamradt; G Tenti; A Mattei; M Müntener; S Subotic; H-P Schmid; P Rüesch Journal: Urologe A Date: 2018-02 Impact factor: 0.639
Authors: Michael A Diefenbach; Catherine Benedict; Suzanne M Miller; Annette L Stanton; Mary E Ropka; Kuang-Yi Wen; Linda G Fleisher; Nihal E Mohamed; Simon J Hall Journal: Transl Behav Med Date: 2018-11-21 Impact factor: 3.046
Authors: Rachel E Patzer; Laura McPherson; Mohua Basu; Sumit Mohan; Michael Wolf; Mariana Chiles; Allison Russell; Jennifer C Gander; John J Friedewald; Daniela Ladner; Christian P Larsen; Thomas Pearson; Stephen Pastan Journal: Am J Transplant Date: 2018-03-26 Impact factor: 8.086
Authors: Erin K Tagai; Suzanne M Miller; Alexander Kutikov; Michael A Diefenbach; Ronak A Gor; Tahseen Al-Saleem; David Y T Chen; Sara Fleszar; Gem Roy Journal: J Cancer Educ Date: 2019-06 Impact factor: 2.037